Relay Therapeutics Company
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Investors
Founded Date:
2016-01-01
Total Funding:
1170000000.0
Employee Number:
101-250
Funding Status:
IPO
Technology:
Biotechnology, Health Care, Therapeutics
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
1
Investors Number:
12.0
Last Funding Date:
2022-09-12
Industry:
End-to-End Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M